No Consistent Link Found Between β-Blockers, Psychiatric Outcomes

WEDNESDAY, March 1, 2023 (HealthDay News) -- There are no consistent links between β-blockers and psychiatric outcomes, according to a study published online Jan. 31 in PLOS Medicine.
Yasmina Molero, Ph.D., from the Karolinska Institutet in Stockholm, and colleagues conducted a population-based longitudinal study to examine the associations between β-blockers and psychiatric and behavioral outcomes. Data were included for 1,400,766 individuals aged 15 years or older who were followed for eight years between 2006 and 2013.
The researchers found that during the study period, 6.9, 0.7, and 0.7 percent of the β-blocker users were hospitalized for a psychiatric disorder, presented with suicidal behavior, and were charged with a violent crime, respectively. Heterogeneity was seen in the direction of the results; periods of β-blocker treatment were associated with reduced risks for psychiatric hospitalizations and charges of violent crime but with increased risks for suicidal behavior (hazard ratios, 0.92, 0.87, and 1.08, respectively). Reduced associations with psychiatric hospitalizations during β-blocker treatment were mainly related to lower hospitalization rates due to depressive and psychotic disorders after stratification by diagnosis (hazard ratios, 0.92 and 0.89, respectively). In most sensitivity analyses, reduced associations with violent charges remained, while inconsistent associations were seen with psychiatric hospitalizations and suicidal behaviors.
"The differing treatment patterns for psychiatric hospitalizations and violent crime suggest that nonspecific treatment effects were not prominent. The increased links with suicidal behavior could suggest that associations were not specific (i.e., causally related) to β-blockers," the authors write.
One author disclosed financial ties to the pharmaceutical industry.
Related Posts
U.S. Could Face Surging Numbers of Teens With Diabetes
FRIDAY, Dec. 30, 2022 (HealthDay News) – The United States could see a huge rise...
Migraine Tied to Lower Cognitive, Language Function
WEDNESDAY, Aug. 31, 2022 (HealthDay News) -- Cognitive function and language...
Study Explores Employment, Economic Consequences of mTBI
THURSDAY, June 30, 2022 (HealthDay News) -- Mild traumatic brain injury (mTBI)...
FDA Eases Access to Cheaper Over-the-Counter Hearing Aids
TUESDAY, Oct. 19, 2021 (HealthDay News) -- Affordable over-the-counter hearing...